Catasys (CATS) Downgraded to “Hold” at Zacks Investment Research

Catasys (NASDAQ:CATS) was downgraded by Zacks Investment Research from a “strong-buy” rating to a “hold” rating in a report released on Monday.

According to Zacks, “Catasys, Inc., formerly known as Hythiam, Inc., provides specialized behavioral health management services to health plans, employers and unions through a network of licensed and company managed health care providers. The Company’s program seeks to improve member health by delivering medical and psychosocial interventions in combination with long term care coaching, including their proprietary treatment program for alcoholism and stimulant dependence. Catasys, Inc. is based in Los Angeles. “

Other research analysts have also recently issued research reports about the company. ValuEngine cut Catasys from a “strong-buy” rating to a “buy” rating in a research note on Monday, February 4th. TheStreet upgraded Catasys from an “e+” rating to a “c” rating in a research note on Thursday, November 29th.

Shares of CATS stock traded up $0.35 during mid-day trading on Monday, hitting $12.39. The company’s stock had a trading volume of 83,994 shares, compared to its average volume of 96,381. Catasys has a 52-week low of $4.03 and a 52-week high of $14.29. The stock has a market capitalization of $194.33 million, a P/E ratio of -14.58 and a beta of 1.82.

Catasys (NASDAQ:CATS) last posted its quarterly earnings results on Wednesday, November 14th. The company reported ($0.27) earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.29) by $0.02. The business had revenue of $4.37 million during the quarter, compared to analysts’ expectations of $4.00 million. Analysts expect that Catasys will post -1.05 EPS for the current year.

Several hedge funds have recently bought and sold shares of CATS. JPMorgan Chase & Co. increased its position in Catasys by 205.5% during the third quarter. JPMorgan Chase & Co. now owns 10,418 shares of the company’s stock valued at $134,000 after acquiring an additional 7,008 shares during the last quarter. Engineers Gate Manager LP purchased a new stake in Catasys during the third quarter valued at $139,000. Ancora Advisors LLC purchased a new stake in Catasys during the third quarter valued at $191,000. B. Riley Wealth Management Inc. purchased a new stake in Catasys during the third quarter valued at $217,000. Finally, Westwood Management Corp IL increased its position in Catasys by 33.3% during the fourth quarter. Westwood Management Corp IL now owns 40,000 shares of the company’s stock valued at $375,000 after acquiring an additional 10,000 shares during the last quarter. Hedge funds and other institutional investors own 10.45% of the company’s stock.

About Catasys

Catasys, Inc provides big data predictive analytics, artificial intelligence and telehealth, combined with human intervention services to health plans and other third party payors. It offers OnTrak solution to improve treatment outcomes and lower the utilization of medical and behavioral health plan services.

See Also: Price to Earnings Ratio (PE)

Get a free copy of the Zacks research report on Catasys (CATS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Catasys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catasys and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply